Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Fish and Richardson
Federal Trade Commission
Johnson and Johnson

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205082

« Back to Dashboard
NDA 205082 describes DESOXIMETASONE, which is a drug marketed by Teligent Pharma Inc, Lupin Atlantis, Akorn, Perrigo New York, Glenmark Generics, Altana, G And W Labs Inc, Perrigo Israel, Fougera Pharms, Actavis Mid Atlantic, Rising Pharms Inc, and Novel Labs Inc, and is included in twenty-three NDAs. It is available from eleven suppliers. Additional details are available on the DESOXIMETASONE profile page.

The generic ingredient in DESOXIMETASONE is desoximetasone. There are seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.

Summary for NDA: 205082

Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)

Pharmacology for NDA: 205082

Suppliers and Packaging for NDA: 205082

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CREAM;TOPICAL 205082 ANDA Actavis Pharma, Inc. 0472-0478 0472-0478-15 1 TUBE in 1 CARTON (0472-0478-15) > 15 g in 1 TUBE
CREAM;TOPICAL 205082 ANDA Actavis Pharma, Inc. 0472-0478 0472-0478-60 1 TUBE in 1 CARTON (0472-0478-60) > 60 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.25%
Approval Date:Sep 4, 2015TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Boehringer Ingelheim
US Army
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:

Google Plus